01July

Novo Nordisk to cease distribution of Tresiba® in Germany ... Read more

26June

Levemir® receives positive CHMP opinion for extended use in children as young as ... Read more

24June

In a phase 3 trial, NovoEight® provided long-term efficacy and safety in the pro ... Read more

07June

New Xultophy® (IDegLira) phase 3b study showed statistically significant HbA1c r ... Read more

06July

Novo Nordisk A/S - Share repurchase programme ... Read more

01July

Status regarding Novo Nordisk's holding of its own shares (30 June 2015) ... Read more

01July

Novo Nordisk A/S - Share repurchase programme ... Read more

22June

Novo Nordisk A/S - Share repurchase programme ... Read more

06August

Financial statement for the first six months of 2015,

07August

Q2 presentation London, London

10August

Q2 roadshow North America,

10August

Q2 roadshow Europe,

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
IR material


Download relevant Investor Relations material

 
Recent event


See information on the ADA 2015 investor and analyst event



Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



Annual report


Download the Novo Nordisk Annual Report



Contacts



Subscriptions


Sign up and follow Novo Nordisk Investors Relations



Financial results


Access key information on the Q1 2015 release